sulforaphane has been researched along with Invasiveness, Neoplasm in 15 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Excerpt | Relevance | Reference |
---|---|---|
"Here we uncovered the involved subcellular mechanisms that sulforaphane-cysteine (SFN-Cys) inhibited invasion in human glioblastoma (GBM)." | 7.96 | Sulforaphane-cysteine inhibited migration and invasion via enhancing mitophagosome fusion to lysosome in human glioblastoma cells. ( Hu, Y; Li, J; Wang, Y; Wu, S; Wu, W; Yan, Y; Zheng, Z; Zhou, Y, 2020) |
"However, its effect on hepatocellular carcinoma remains largely unknown." | 5.43 | Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. ( Deng, C; Han, J; Hou, B; Shen, L; Wu, H; Wu, J, 2016) |
"Sulforaphane (SFN) was demonstrated to inhibit cell growth in a variety of tumors." | 5.40 | Sulforaphane inhibits invasion via activating ERK1/2 signaling in human glioblastoma U87MG and U373MG cells. ( Du, L; Li, C; Niu, J; Peng, X; Tian, H; Wu, W; Yang, G; Zhou, Y, 2014) |
"Here we uncovered the involved subcellular mechanisms that sulforaphane-cysteine (SFN-Cys) inhibited invasion in human glioblastoma (GBM)." | 3.96 | Sulforaphane-cysteine inhibited migration and invasion via enhancing mitophagosome fusion to lysosome in human glioblastoma cells. ( Hu, Y; Li, J; Wang, Y; Wu, S; Wu, W; Yan, Y; Zheng, Z; Zhou, Y, 2020) |
"Sulforaphane is a diet-derived cancer prevention agent that is effective in suppressing tumor growth in animal models of skin cancer." | 1.48 | Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma. ( Adhikary, G; Eckert, RL; George, N; Grun, D; Kerr, C, 2018) |
"However, its effect on hepatocellular carcinoma remains largely unknown." | 1.43 | Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway. ( Deng, C; Han, J; Hou, B; Shen, L; Wu, H; Wu, J, 2016) |
"Advanced prostate cancer has highly invasive potential, which may lead to metastasis associated with poor prognosis." | 1.42 | Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells. ( Geng, Y; Li, C; Peng, X; Tian, H; Wu, S; Wu, W; Yang, G; Zhou, Y, 2015) |
"However, its antitumor effect in thyroid cancer remains largely unknown." | 1.42 | Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway. ( Guan, H; Hou, P; Ji, M; Li, H; Shi, B; Tian, Z; Wang, L; Yang, Q, 2015) |
"Sulforaphane (SFN) was demonstrated to inhibit cell growth in a variety of tumors." | 1.40 | Sulforaphane inhibits invasion via activating ERK1/2 signaling in human glioblastoma U87MG and U373MG cells. ( Du, L; Li, C; Niu, J; Peng, X; Tian, H; Wu, W; Yang, G; Zhou, Y, 2014) |
"Sulforaphane is a predominant isothiocyanate in Brassica oleracea, a family of cruciferous vegetables, and is known to be inversely related to the risk of various types of human carcinomas." | 1.37 | Sulforaphane inhibits oral carcinoma cell migration and invasion in vitro. ( Jee, HG; Kim, JB; Lee, KE; Shin, HK; Youn, YK, 2011) |
"These results are not limited to breast cancer cells since the Nrf2 inducer SFN stabilized Nrf2 and inhibited RON expression in carcinoma cells from various tumor types." | 1.37 | Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion. ( Ammanamanchi, S; Freeman, JW; Krishnegowda, NK; Rogge, J; Thangasamy, A, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 13 (86.67) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Justin, S | 1 |
Rutz, J | 1 |
Maxeiner, S | 1 |
Chun, FK | 1 |
Juengel, E | 1 |
Blaheta, RA | 1 |
Zhou, Y | 4 |
Wang, Y | 1 |
Wu, S | 3 |
Yan, Y | 1 |
Hu, Y | 2 |
Zheng, Z | 1 |
Li, J | 1 |
Wu, W | 4 |
Kerr, C | 1 |
Adhikary, G | 2 |
Grun, D | 2 |
George, N | 1 |
Eckert, RL | 2 |
Saha, K | 1 |
Fisher, ML | 1 |
Hsu, YC | 1 |
Chang, SJ | 1 |
Wang, MY | 1 |
Chen, YL | 1 |
Huang, TY | 1 |
Li, C | 2 |
Peng, X | 2 |
Du, L | 1 |
Tian, H | 3 |
Yang, G | 3 |
Niu, J | 1 |
Geng, Y | 2 |
Wang, L | 1 |
Tian, Z | 1 |
Yang, Q | 1 |
Li, H | 1 |
Guan, H | 1 |
Shi, B | 1 |
Hou, P | 1 |
Ji, M | 1 |
Lee, CS | 1 |
Cho, HJ | 1 |
Jeong, YJ | 1 |
Shin, JM | 1 |
Park, KK | 1 |
Park, YY | 1 |
Bae, YS | 1 |
Chung, IK | 1 |
Kim, M | 1 |
Kim, CH | 1 |
Jin, F | 1 |
Chang, HW | 1 |
Chang, YC | 1 |
Wu, J | 1 |
Han, J | 1 |
Hou, B | 1 |
Deng, C | 1 |
Wu, H | 1 |
Shen, L | 1 |
Rizzo, VL | 1 |
Levine, CB | 1 |
Wakshlag, JJ | 1 |
Lin, K | 1 |
Bryant, CS | 1 |
Kumar, S | 1 |
Chamala, S | 1 |
Shah, J | 1 |
Pal, J | 1 |
Haider, M | 1 |
Seward, S | 1 |
Qazi, AM | 1 |
Morris, R | 1 |
Semaan, A | 1 |
Shammas, MA | 1 |
Steffes, C | 1 |
Potti, RB | 1 |
Prasad, M | 1 |
Weaver, DW | 1 |
Batchu, RB | 1 |
Jee, HG | 1 |
Lee, KE | 1 |
Kim, JB | 1 |
Shin, HK | 1 |
Youn, YK | 1 |
Thangasamy, A | 1 |
Rogge, J | 1 |
Krishnegowda, NK | 1 |
Freeman, JW | 1 |
Ammanamanchi, S | 1 |
15 other studies available for sulforaphane and Invasiveness, Neoplasm
Article | Year |
---|---|
Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Everolimus; Gene Expression Regulation, Neoplas | 2020 |
Sulforaphane-cysteine inhibited migration and invasion via enhancing mitophagosome fusion to lysosome in human glioblastoma cells.
Topics: Cell Line, Tumor; Cell Movement; Cysteine; Glioblastoma; Humans; Isothiocyanates; Lysosomes; Neoplas | 2020 |
Combination cisplatin and sulforaphane treatment reduces proliferation, invasion, and tumor formation in epidermal squamous cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell L | 2018 |
Sulforaphane suppresses PRMT5/MEP50 function in epidermal squamous cell carcinoma leading to reduced tumor formation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Move | 2017 |
Growth inhibition and apoptosis of neuroblastoma cells through ROS-independent MEK/ERK activation by sulforaphane.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinogenesis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Mov | 2013 |
Sulforaphane inhibits invasion via activating ERK1/2 signaling in human glioblastoma U87MG and U373MG cells.
Topics: Anticarcinogenic Agents; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Res | 2014 |
Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells.
Topics: Cadherins; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; I | 2015 |
Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell | 2015 |
Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression.
Topics: Cell Line, Tumor; Cell Movement; Extracellular Matrix; Focal Adhesion Kinase 1; Gene Expression Regu | 2015 |
Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Movement; Cell Shape; Epi | 2016 |
The effects of sulforaphane on canine osteosarcoma proliferation and invasion.
Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Cell Line, | 2017 |
Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Down-Regulat | 2016 |
Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
Topics: Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA | 2010 |
Sulforaphane inhibits oral carcinoma cell migration and invasion in vitro.
Topics: Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Ma | 2011 |
Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Regulation, Enz | 2011 |